Patient Experiences
5 articles on Patient Experiences, written by Shotlee and medically reviewed for clinical accuracy.
Obesity Drug Coverage Restrictions Force Patients to Pivot
For Meghan Lena, losing coverage for Zepbound felt devastating after losing 50 pounds. Now, GoodRx reports 12 million people will lose access to Zepbound and Wegovy from 2025-2026 due to insurance changes. Patients are pivoting to alternatives amid rising restrictions and costs.
8 min read
1 in 10 Wegovy and Ozempic Users Lose Less Than 5% Body Weight
Trials show one in ten people on Wegovy and Ozempic lose less than 5% of their body weight, challenging the drugs' reputation as a universal solution. Patient experiences like Samantha Jess's highlight non-responder realities, while experts explain genetic and metabolic factors. Discover why GLP-1 agonists work for some but not others.
6 min read
Mysterious Flat Affect Symptom in GLP-1 Users
Patients on GLP-1 medications are reporting a puzzling flat affect—not depression, but a sense of 'what's the point?' toward life goals and social plans. One doctor noticed this in three patients within a week, prompting deeper research into GLP-1s' impact on dopamine and motivation. Could this be an emerging side effect?
5 min read
Bunnie Xo Reveals 'Horrific' Suicidal Ideation from GLP-1 Medication
Jelly Roll's wife, Bunnie Xo, described a 'horrific' bout of suicidal ideation as a side effect from taking a GLP-1 medication last year. The Dumb Blonde podcast host opened up to PEOPLE about this dark period, emphasizing the need for open conversations on GLP-1 side effects. Despite family diabetes history prompting her use, she urges others: 'Please stay.'
6 min read
GLP-1 Medications: Patient Stories, Science & Real Risks
GLP-1 medications like Zepbound have transformed lives, helping patients lose significant weight amid personal challenges. But rapid results come with risks like gallstones and muscle loss. This guide blends real stories with clinical insights for informed decisions.
4 min read